Uncovering mediators of collagen degradation in the tumor microenvironment

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,28 MB, PDF-dokument

Increased remodeling of the extracellular matrix in malignant tumors has been shown to correlate with tumor aggressiveness and a poor prognosis. This remodeling involves degradation of the original extracellular matrix (ECM) and deposition of a new tumor-supporting ECM. The main constituent of the ECM is collagen and collagen turnover mainly occurs in a sequential manner, where initial proteolytic cleavage of the insoluble fibers is followed by cellular internalization of large well-defined collagen fragments for lysosomal degradation. However, despite extensive research in the field, a lack of consensus on which cell types within the tumor microenvironment express the involved proteases still exists. Furthermore, the relative contribution of different cell types to collagen internalization is not well-established. Here, we developed quantitative ex vivo collagen degradation assays and show that the proteases responsible for the initial collagen cleavage in two murine syngeneic tumor models are matrix metalloproteinases produced by cancer-associated fibroblasts and that collagen degradation fragments are endocytosed primarily by tumor-associated macrophages and cancer-associated fibroblasts from the tumor stroma. Using tumors from mannose receptor-deficient mice, we show that this receptor is essential for collagen-internalization by tumor-associated macrophages. Together, these findings identify the cell types responsible for the entire collagen degradation pathway, from initial cleavage to endocytosis of fragments for intracellular degradation.

OriginalsprogEngelsk
Artikelnummer100101
TidsskriftMatrix Biology Plus
Vol/bind13
ISSN2590-0285
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
We thank Signe Ingvarsen for critically reviewing the manuscript. This work was supported by the Danish Cancer Society (DHM and MLT grant no. R174-A11581-17-S52; DHM and MC grant no. R231-A14035; NB grant no. R146-A9326-16-S2, R231-A13820; HJJ grant no. R90-A5989), The Lundbeck Foundation (DHM grant no. R307-2018-3326) The Danish Medical Research Council (NB grant no. DFF-4004-00340), The Novo Nordisk Foundation (NB), Krista and Viggo Petersen’s Foundation (NB), The Research Foundation of the Danish Capital Region (NB), The Danish Research Foundation (NW and CJ), Independent Research Fund Denmark (HJJ grant no. 4092-00387B).

Funding Information:
We thank Signe Ingvarsen for critically reviewing the manuscript. This work was supported by the Danish Cancer Society (DHM and MLT grant no. R174-A11581-17-S52; DHM and MC grant no. R231-A14035; NB grant no. R146-A9326-16-S2, R231-A13820; HJJ grant no. R90-A5989), The Lundbeck Foundation (DHM grant no. R307-2018-3326) The Danish Medical Research Council (NB grant no. DFF-4004-00340), The Novo Nordisk Foundation (NB), Krista and Viggo Petersen's Foundation (NB), The Research Foundation of the Danish Capital Region (NB), The Danish Research Foundation (NW and CJ), Independent Research Fund Denmark (HJJ grant no. 4092-00387B).

Publisher Copyright:
© 2022 The Author(s)

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 298635187